A PHASE IB TRIAL OF MURINE MONOCLONAL ANTIBODY R24 (ANTI-GD3) IN METASTATIC MELANOMA

Publisher Website

1 February 1992

journal article
Published by Wolters Kluwer Health in Journal of Immunotherapy

Vol. 11 (2) , 130
https://doi.org/10.1097/00002371-199202000-00030

Abstract

No abstract available

Cited by 1 article